Home » Authors » James Etheridge

James Etheridge

Articles

ARTICLES

DAS Seeking €20M Through Private Round, Stock Listing

June 21, 2006

By James Etheridge

No Abstract

France's First Private Stem Cell Bank Seeking Funding

June 14, 2006

By James Etheridge

Trophos To Test Lead Drug Against Diabetic Neuropathy

June 14, 2006

By James Etheridge

Trophos To Test Lead Drug Against Diabetic Neuropathy

June 14, 2006

By James Etheridge

France's First Private Stem Cell Bank Seeking Funding

June 14, 2006

By James Etheridge

Immutep Completes Phase I Trial, Seeks €13M From VCs

June 7, 2006

By James Etheridge

Immutep Completes Phase I Trial, Seeks €13M From VCs

June 7, 2006

By James Etheridge

No Abstract

Topigen Starts Phase II Trials Of Former NicOx Compound

May 31, 2006

By James Etheridge

Topigen Starts Phase II Trials Of Former NicOx Compound

May 31, 2006

By James Etheridge

BioAlliance Starting Phase III Trial, Exploring Opportunities

May 24, 2006

By James Etheridge

View All Articles by James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...